<DOC>
	<DOC>NCT01878643</DOC>
	<brief_summary>The purpose of this study was : - to determine the effect of inhaled antibiotics on airway bacteria in ventilated patients - to determine the effect of inhaled antibiotics on respiratory infection</brief_summary>
	<brief_title>Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit</brief_title>
	<detailed_description>Double-blind randomized placebo controlled study examining the effect of aerosolized antibiotics on respiratory infection signs and symptoms and on bacterial eradication and resistance. Systemic antibiotics are administered by the responsible physician</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<criteria>be on mechanical ventilation greater than 3 days greater than or equal to 18 years and survival greater than 14 days organisms on Gram stain with increasing purulent secretions pregnancy allergy to drugs administered</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>aerosolized antibiotic</keyword>
	<keyword>ventilator-associated pneumonia</keyword>
	<keyword>bacterial resistance</keyword>
	<keyword>ventilator -associated tracheobronchitis</keyword>
	<keyword>clinical pulmonary infection score</keyword>
</DOC>